THE USE OF PROSTATE-SPECIFIC ANTIGEN AS A SURROGATE END POINT IN THE TREATMENT OF PATIENTS WITH HORMONE REFRACTORY PROSTATE CANCER
Smith, David C., Pienta, Kenneth J.Volume:
24
Language:
english
Journal:
Urologic Clinics of North America
DOI:
10.1016/S0094-0143(05)70390-6
Date:
May, 1997
File:
PDF, 360 KB
english, 1997